KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat.
New insights reveal EGFR as a target in KRAS-mutated colon cancer
- Post author:admin
- Post published:May 26, 2025
- Post category:uncategorized
- Post comments:0 Comments